Location of Repository

In vitro activity of Etanidazole against the protozoan parasite Trypanosoma cruzi

By Patricia B Petray, María J Morilla, Ricardo S Corral and Eder L Romero

Abstract

We investigated the in vitro action of an hydrosoluble 2-nitroimidazole, Etanidazole (EZL), against Trypanosoma cruzi, the etiologic agent of Chagas disease. EZL displayed lethal activity against isolated trypomastigotes as well as amastigotes of T. cruzi (RA strain) growing in Vero cells or J774 macrophages, without affecting host cell viability. Although not completely equivalent to Benznidazole (BZL), the reference drug for Chagas chemotherapy, EZL takes advantage in exertingits anti-T. cruzi activity for longer periods without serious toxic side effects, as those recorded in BZL-treated patients. Our present results encourage further experiments to study in depth the trypanocidal properties of this drug already licensed for use in human cancers

Topics: Trypanosoma cruzi, Etanidazole, chemotherapy, Microbiology, QR1-502, Science, Q, DOAJ:Microbiology, DOAJ:Biology, DOAJ:Biology and Life Sciences, Arctic medicine. Tropical medicine, RC955-962, Special situations and conditions, RC952-1245, Internal medicine, RC31-1245, Medicine, R, DOAJ:Internal medicine, DOAJ:Medicine (General), DOAJ:Health Sciences
Publisher: Instituto Oswaldo Cruz, Ministério da Saúde
Year: 2004
DOI identifier: 10.1590/S0074-02762004000200021
OAI identifier: oai:doaj.org/article:b975ae85e1f74f0f95bf42afd782e842
Journal:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://doaj.org/toc/1678-8060 (external link)
  • https://doaj.org/toc/0074-0276 (external link)
  • http://www.scielo.br/scielo.ph... (external link)
  • https://doaj.org/article/b975a... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.